Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Uniqure Ord Shs (NQ: QURE )

35.97 USD UNCHANGED
Streaming Delayed Price Updated: 4:01 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Uniqure Ord Shs

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
10 Biggest Price Target Changes For Tuesday
Rosenblatt boosted Zoom Video Communications, Inc. (NASDAQ: ZM) price target from $350 to $400. Zoom Video shares rose 7.2% to ... 
Tags AI Price Target Market News
From Benzinga
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
From GlobeNewswire News Releases
uniQure to Participate in Multiple Upcoming Industry Conferences in March
From GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VLON NK RNA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday's morning session saw 3 companies set new 52-week lows. Significant Points: McCormick & Co ... 
Tags Movers SQZ Trading Ideas
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News QURE TLIS
From Benzinga
Uniqure Stock Pops After Panel Says Gene Therapy Study Can Continue
Uniqure said Monday an independent panel recommended it continue enrolling patients in a study of its Huntington's disease gene therapy. In response, QURE stock popped on the news. 
From Investor's Business Daily
No Safety Concerns Observed In Uniqure's Early-Stage Huntington's Gene Therapy Study, DSMB Says
Independent Data Safety Monitoring Board (DSMB) hasreviewed the six-month safety datafrom the first two enrolled patients ... 
Tags News Benzinga General
From Benzinga
uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
From GlobeNewswire News Releases
Look Under The Hood: RYJ Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
uniQure to Participate in Multiple Upcoming Industry Conferences in February
From GlobeNewswire News Releases
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning the emergence of a new strain of coronavirus in the U.K. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning ... 
Tags CHRS Biotech KNTE
From Benzinga
Analysts Anticipate MOON Will Reach $38
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
82 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ... 
Tags Movers From Yesterday QUIK TARS
From Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; uniQure Shares Slide
Toward the end of trading Monday, the Dow traded up 0.30% to 30,270.96 while the NASDAQ fell 0.14% to 12,737.93. The S&P also fell, ... 
Tags News Benzinga Penny Stocks
From Benzinga
Why uniQure Stock Is Tanking Today
A clinical hold is weighing on the biotech's shares today. 
Tags Market News QURE
From Motley Fool
Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives
Crispr Therapeutics, Editas Medicine and Intellia Therapeutics were ablaze Monday as all three genetics stocks hit highs. Uniqure stock tumbled on a clinical hold for its gene therapy test. 
From Investor's Business Daily
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers NantKwest (NASDAQ:NK) stock rose 57.4% to $16.15 during Monday's regular session. As of 12:31 EST, this ... 
Tags SNDL SNCA Movers
From Benzinga
Mid-Day Market Update: Crude Oil Down 4%; 500.com Shares Spike Higher
Midway through trading Monday, the Dow traded down 0.51% to 30,026.31 while the NASDAQ fell 0.89% to 12,642.15. The S&P also fell, ... 
Tags OCC NK Eurozone
From Benzinga
55 Stocks Moving In Monday's Mid-Day Session
Gainers 500.com Limited (NYSE: WBAI) shares climbed 125.7% to $6.07 after the company announced a $23 million investment from ... 
Tags Markets AIM QEP
From Benzinga
Mid-Morning Market Update: Markets Open Lower; FactSet Research Beats Q1 Estimates
Following the market opening Monday, the Dow traded down 1.31% to 29,782.55 while the NASDAQ fell 1.74% to 12,533.20. The S&P also ... 
Tags SI WNW News
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 84.31% to $6.58 during Monday's pre-market ... 
Tags DBVT HSTO CRBP
From Benzinga
UniQure Plunges As FDA Slaps Clinical Hold On Hemophilia B Gene Therapy Study On Possible Liver Cancer Link
Uniqure NV (NASDAQ: QURE) shares are moving sharply to the downsideafter the gene therapy company announced a setback to its ... 
Tags Benzinga News Biotech
From Benzinga
uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program
Company to hold conference call today at 8:30 a.m. ET 
From GlobeNewswire News Releases
4 Biotechs That Could Be Potential Acquisition Targets in 2021
Stocks of these companies have not fully recovered from the stock-market crash in March 2020, suggesting attractive valuations. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
Eli Lilly agreed to buy gene therapy company Prevail Therapeutics for $1.04 billion on Tuesday, sending PRVL stock to a record high. The deal is worth $880 million up front and a CVR. 
From Investor's Business Daily
This Gene Therapy Stock Is Ablaze On Eli Lilly's $1.04 Billion Takeover
Eli Lilly agreed to buy gene therapy company Prevail Therapeutics for $1.04 billion on Tuesday, sending PRVL stock to a record high. The deal is worth $880 million up front and a CVR. 
From Investor's Business Daily
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CMRX RPRX FATE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account